Medical breakthroughs, wellbeing stories, and health heroes.
Interim results from a 24-patient Calgary study suggest high-dose niacin, given under strict medical supervision, may help some glioblastoma patients stay free of progression for longer
Researchers in Budapest, writing with a Glasgow professor, say pain that outlasts inflammation may be a reason to look at the wider picture rather than automatically add more medication.
A study of nearly 49,000 MRI scans links several conditions to brains that look older than expected. It found no overall difference for ADHD or autism, and it does not show cause.
Research prepared for a major European diabetes meeting suggests that some fluctuation within safe limits may go hand in hand with brighter days, though it is no reason to change your routine without speaking to your care team
King's College London scientists found urolithin A helped stiff heart tissue relax in animal and lab studies. Researchers stress it is early days, and pomegranates are not medicine.
The SINGLE-AF study found a 69% relative drop in serious events for people with atrial fibrillation at "intermediate" stroke risk — without a rise in major bleeding
A single gene-editing infusion that silences a cholesterol-regulating gene has kept LDL and triglycerides down for a full year in a small Cleveland Clinic trial — an early but genuinely encouraging step for people with hard-to-treat lipid disorders.
Glasgow joins a UK-wide consortium putting the voices of people living with the condition at the heart of a five-year, Arthritis UK-funded study
NHS Greater Glasgow and Clyde teams praised by parents and bosses alike as Scotland's busiest health board marks International Day of the Midwife
NHSGGC's perinatal mental health team has helped more than 250 women through wellbeing workshops — and they want every expectant mum to know support is one phone call away
Glasgow's thrombectomy suite is one of a small but growing number of UK units pulling clots from the brain with a tiny wire cage — and the results are transforming recovery
A Nobel-winning discovery is heading from the laboratory to the clinic, with US regulators tipped to approve the first regulatory T cell therapy as early as this year.
The first new class of pain medicine in over 25 years blocks signals before they reach the brain — and UK patients could be next in line
A team at Fred Hutchinson Cancer Center has created human-like antibodies that stop Epstein-Barr virus from getting into immune cells. For the millions living with EBV-linked illnesses, it's the biggest step forward in years.
A first-of-its-kind regulatory T cell treatment is inching towards FDA approval — and could rewrite the rules for transplant medicine
After two decades with no major innovation in pain relief, a new drug that blocks pain at the nerve — not the brain — is offering genuine hope for an opioid-free future
Pre-clinical Penn-led study, published in Nature, targets the brain's pain circuits directly — but human trials are still some way off
Seattle scientists engineer human antibodies that block Epstein-Barr virus — with transplant patients first in line to benefit
Major UK evaluation finds AI tool detects more breast cancers, faster, while easing pressure on overstretched NHS staff — with a nationwide rollout on the horizon
A simple blood draw could replace invasive spinal taps and costly brain scans, bringing Alzheimer's diagnosis to your GP's surgery
CAR-T therapy obe-cel has been called 'very sci-fi' by its first NHS patient — and Scotland's families are watching closely as the Scottish Medicines Consortium weighs approval
Suzetrigine, the first new class of painkiller in over 20 years, matches opioid-level pain relief without the dangers of addiction — and experts say it could be just the beginning
As the Our Health Heroes Awards mark their 10th anniversary, the spotlight falls on the porters, cleaners, and receptionists the NHS couldn't function without
Drops made from pig-derived lipids shrank childhood eye cancer tumours by 97% in mice — offering hope for less invasive treatment for the youngest cancer patients
NICE has approved semaglutide for cardiovascular disease prevention, but Scotland's own drug approval body has yet to set a date for its review — and Scotland has the UK's worst heart disease rates
Stanford researchers discover that chronic pain runs on its own dedicated brain circuit, opening the door to treatments that could switch it off without dulling the body's vital warning system
A £26 million UK-wide clinical trial aims to find the first treatment that can slow the progression of Parkinson's disease. More than 1,600 people have already signed up — and three Scottish hospitals are preparing to open their doors.
From open water swimming at Pinkston to Parkrun at Queen's Park, a quiet revolution is replacing punishment with joy
Millie Childs first imagined a solution to her reading struggles at age eight. Now her Rainbow Glasses have attracted NHS interest — and could help millions.
Occupational therapy student Najma Omar created SereniHijab for her autistic sister Nasteho. Now the sensory-friendly design is sparking a quiet revolution in inclusive clothing.
A £100 blood test measuring a single protein could transform dementia diagnosis from guesswork to science. Scotland's NHS is evaluating how to bring it into routine care.
A twice-yearly injection approved in December could transform HIV prevention for those failed by daily pills — and Scotland is already leading the way
After decades of nothing, disease-modifying treatments are changing the Alzheimer's landscape. Now the fight is to get them on the NHS.
A UCL-led trial has shown a single brain surgery can slow the devastating disease by 75% — and Scotland, with some of the highest rates in the world, stands to benefit most
The NHS hospital on the banks of the Clyde performed more than 4,300 joint replacements last year — and it's just getting started.
The UK government's National Cancer Plan targets 75% five-year cancer survival by 2035 — the fastest improvement this century, translating to 320,000 more lives saved.
Researchers in France have uncovered hidden mechanics of metastasis, opening the door to therapies that could one day stop cancer in its tracks.
A cancer patient 1,500 miles away received specialist robotic surgery without leaving his local hospital — a breakthrough that could reshape access to healthcare.